Pramipexole Basic information
Product Name: Pramipexole
CAS: 191217-81-9
MF: C10H21Cl2N3OS
MW: 302.26

Description: Pramipexole is the product used to treat idiopathic Parkinson's disease signs and symptoms alone (without levodopa) or combined with levodopa.
Pharmacological effects: Pramipexole is a non-ergot dopamine agonist class. In vitro studies showed that pramipexole high specificity for the D2 receptor and has full intrinsic activity, affinity for D3 receptors than D2 and D4 receptor. And D3 receptors Pramipexole This combination of role and relevance of Parkinson's disease is not clear. Pramipexole treatment of Parkinson's disease the exact mechanism is not clear at present that with the activation of striatal dopamine receptors. Animal electrophysiological experiments showed that pramipexole can activate the striatum and substantia nigra of the striatal dopamine receptors affect neuronal firing frequency.
Physical Properties: white or white crystalline powder
Packing: 1 kg per bag or according to customer requirements
Quality Standard: Enterprise standard content of 99%
Storage conditions: light moisture sealed and dry.